Teva CEO Levin Steps Down in Revamp Dispute With Board

Teva Pharmaceutical Industries Ltd. Chief Executive Officer Jeremy Levin stepped down after less than 18 months on the job in a dispute with Chairman Phillip Frost over how to restructure the world’s biggest generic-drug maker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.